Valuation: ZIM Laboratories Limited

Market Cap 6.33B 66.33M 58.09M 53.5M 49.66M 94.31M 95.58M 640M 249M 3.11B 249M 244M 10.77B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.19B 75.38M 66.01M 60.8M 56.44M 107M 109M 728M 283M 3.53B 283M 277M 12.24B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.65%
Yield 2025 *
-
Yield 2026 -
1 day-1.99%
1 week-4.95%
Current month-4.95%
1 month+14.21%
3 months+72.28%
6 months+68.74%
Current year+64.35%
1 week 118.15
Extreme 118.15
125
1 month 103.45
Extreme 103.45
133.95
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%-4.95%+6.63%+11.67% 67.67M
-0.49%+2.20%+13.30%+83.78% 48.11B
-1.41%+6.57%+71.07%+120.76% 37.88B
-1.39%-0.93%-3.89%+42.24% 12.47B
+0.44%+3.63%+15.44%+98.02% 12B
+1.82%+2.76%+34.19%+120.25% 9.03B
0.00%+2.07%+22.51%+48.19% 7.24B
+0.41%+2.95%+56.10%-2.71% 7.09B
-0.62%+21.06%-16.02%+24.43% 6.54B
-0.26%+2.75%+21.76%+228.60% 6.72B
Average -0.36%+4.46%+22.11%+77.53% 14.71B
Weighted average by Cap. -0.52%+4.49%+29.77%+91.21%

Financials

2025 2026
Net sales 3.79B 39.75M 34.81M 32.06M 29.76M 56.51M 57.28M 384M 149M 1.86B 149M 146M 6.45B 3.74B 39.25M 34.38M 31.66M 29.39M 55.81M 56.56M 379M 147M 1.84B 147M 144M 6.37B
Net income 122M 1.28M 1.12M 1.03M 955K 1.81M 1.84M 12.31M 4.79M 59.71M 4.79M 4.68M 207M 58.38M 612K 536K 494K 458K 870K 882K 5.91M 2.3M 28.66M 2.3M 2.25M 99.36M
Net Debt 1.16B 12.14M 10.63M 9.79M 9.09M 17.26M 17.49M 117M 45.61M 568M 45.58M 44.58M 1.97B 863M 9.05M 7.92M 7.3M 6.77M 12.87M 13.04M 87.37M 34M 424M 33.98M 33.23M 1.47B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-07-07 118.15 -1.99% 857
26-07-06 ₹120.55 -1.99% 732
26-07-03 ₹123.00 -0.08% 2,591
26-07-02 ₹123.10 -1.52% 3,718
26-07-01 ₹125.00 +0.56% 8,541
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock